Get the Stockscreener App
0.8122
10.04%
-0.0878
Cardlytics Inc Stock (CDLX) Forecast
The Cardlytics Inc (CDLX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $129.56, representing a +15,852% increase from the current price of $0.8122. The highest analyst price target is $154.44, and the lowest is $104.68.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CDLX Price Target
Average 104.28
(+12,740% Upside)
Is Cardlytics Inc (CDLX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.05 | Neutral |
| STOCH(9,6) | 24.31 | Neutral |
| STOCHRSI(14) | 12.44 | Buy |
| MACD(12,26) | -0.0578 | Buy |
| ADX(14) | 16.78 | Neutral |
| William %R | -82.36 | Buy |
| CCI(14) | -115.66 | Sell |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8619
Sell
|
0.8629
Sell
|
| MA20 |
0.8907
Sell
|
0.9023
Sell
|
| MA50 |
1.0534
Sell
|
1.0292
Sell
|
| MA100 |
1.2711
Sell
|
1.2168
Sell
|
| MA200 |
1.5074
Sell
|
1.5967
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CDLX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CDLX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.05 indicates that CDLX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.31 indicates that CDLX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.44 indicates that CDLX is oversold. This suggests that CDLX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.78 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -115.66 indicates that CDLX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CDLX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cardlytics Inc financial reports and earnings history, Cardlytics Inc (CDLX) stock could reach $10.34 by 2030, $10.29 by 2040 and $33.12 by 2050. See the projected annual prices until 2050 of the Cardlytics Inc stock below:
- Cardlytics Inc (CDLX) is expected to reach an average price of $2.7582 in 2035, with a high prediction of $3.5393 and a low estimate of $0.3268. This indicates an $239.59% rise from the last recorded price of $0.8122.
- Cardlytics Inc (CDLX) stock is projected to chart a bullish course in 2040, with an average price target of $10.48, representing an $1,190% surge from its current level. The forecast ranges from a conservative $10.83 to a sky-high $10.29.
- Our analysts predict Cardlytics Inc (CDLX) to jump 1,771% by 2045, soaring from $12.75 to an average price of $15.19, potentially reaching $13.97. While $12.75 is the low estimate, the potential upside is significant.
- Cardlytics Inc (CDLX) stock is expected to climb by 2050, reaching an average of $22.47, a $2,666% jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.12 and $10.33, respectively, highlighting the market's uncertainty.
Cardlytics Inc Stock (CDLX) Year by Year Forecast
Cardlytics Inc Stock (CDLX) Price Forecast for 2026
The predicted value for Cardlytics Inc (CDLX) in 2026 is set at an average of $110.49. Estimates vary from a peak of $154.44 to a trough of $66.53, indicating an +13,504% surge from the present price of $0.8122.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $145.02 | $104.68 | $154.44 | +17,756% |
| May, 2026 | $120.88 | $111.37 | $145.70 | +14,783% |
| June, 2026 | $103.96 | $98.38 | $123.34 | +12,700% |
| July, 2026 | $85.45 | $78.74 | $138.09 | +10,421% |
| August, 2026 | $105.62 | $80.91 | $106.15 | +12,905% |
| September, 2026 | $116.66 | $95.39 | $124.02 | +14,263% |
| October, 2026 | $81.72 | $76.93 | $128.15 | +9,962% |
| November, 2026 | $84.07 | $68.58 | $85.28 | +10,251% |
| December, 2026 | $77.29 | $76.76 | $92.77 | +9,416% |
Cardlytics Inc Stock (CDLX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cardlytics Inc (CDLX) is $48.23, with a high forecast of $90.62 and a low forecast of $5.8323. This indicates an +5,838% increase from the last price of $0.8122.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $76.62 | $71.14 | $79.97 | +9,333% |
| February, 2027 | $65.23 | $64.50 | $90.62 | +7,931% |
| March, 2027 | $60.06 | $54.12 | $67.70 | +7,295% |
| April, 2027 | $58.90 | $49.59 | $65.24 | +7,151% |
| May, 2027 | $61.05 | $49.65 | $64.80 | +7,417% |
| June, 2027 | $47.51 | $44.16 | $66.99 | +5,750% |
| July, 2027 | $48.64 | $35.75 | $56.55 | +5,889% |
| August, 2027 | $32.46 | $30.87 | $52.54 | +3,896% |
| September, 2027 | $21.43 | $18.89 | $34.31 | +2,539% |
| October, 2027 | $16.98 | $15.02 | $23.67 | +1,991% |
| November, 2027 | $12.87 | $12.81 | $21.39 | +1,484% |
| December, 2027 | $10.66 | $5.8323 | $12.36 | +1,212% |
Cardlytics Inc Stock (CDLX) Price Forecast for 2028
In 2028, Cardlytics Inc (CDLX) is projected to reach an average price of $5.7044, with a high projection of $11.38 and a low estimate of $0.0297. This indicates an +602.34% rise from the last price of $0.8122.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.811 | $5.671 | $11.38 | +615.46% |
| February, 2028 | $3.3835 | $2.6635 | $8.3122 | +316.58% |
| March, 2028 | $3.4666 | $1.0847 | $4.3541 | +326.82% |
| April, 2028 | $1.8909 | $1.5518 | $4.3572 | +132.81% |
| May, 2028 | $1.0478 | $0.9984 | $1.3903 | +29.00% |
| June, 2028 | $0.5753 | $1.1459 | $0.3835 | -29.17% |
| July, 2028 | $0.5772 | $0.4472 | $3.3265 | -28.93% |
| August, 2028 | $1.9897 | $0.2115 | $1.5978 | +144.97% |
| September, 2028 | $0.2778 | $2.4268 | $2.2878 | -65.79% |
| October, 2028 | $0.3853 | $0.0447 | $3.2103 | -52.56% |
| November, 2028 | $0.1184 | $0.2191 | $0.8659 | -85.42% |
| December, 2028 | $0.7709 | $0.0297 | $1.3803 | -5.08% |
Cardlytics Inc Stock (CDLX) Price Forecast for 2029
The 2029 price forecast for Cardlytics Inc Stock (CDLX) is $7.8003 on average, with a high prediction of $15.45 and a low estimate of $0.1516. This represents an +860.39% increase from the previous price of $0.8122.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.1741 | $0.1516 | $6.1941 | +660.16% |
| February, 2029 | $7.9566 | $5.4147 | $9.7147 | +879.63% |
| March, 2029 | $13.74 | $8.0472 | $14.16 | +1,592% |
| April, 2029 | $5.6715 | $5.4515 | $13.90 | +598.29% |
| May, 2029 | $0.7947 | $0.3947 | $8.8547 | -2.16% |
| June, 2029 | $3.2272 | $0.7153 | $4.0553 | +297.34% |
| July, 2029 | $3.9797 | $2.2884 | $4.4497 | +389.98% |
| August, 2029 | $2.4628 | $0.5721 | $3.8503 | +203.22% |
| September, 2029 | $1.8153 | $0.844 | $3.2486 | +123.50% |
| October, 2029 | $10.82 | $1.7571 | $11.81 | +1,232% |
| November, 2029 | $7.1809 | $6.6509 | $15.45 | +784.13% |
| December, 2029 | $4.87 | $0.27 | $8.5927 | +499.61% |
Cardlytics Inc Stock (CDLX) Price Forecast for 2030
Cardlytics Inc Stock (CDLX) is expected to reach an average price of $47.61 in 2030, with a high forecast of $92.22 and a low forecast of $3.0125. This signifies an +5,762% surge from the last price of $0.8122.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.0062 | $3.0125 | $10.34 | +1,009% |
| February, 2030 | $12.11 | $6.5975 | $14.16 | +1,391% |
| March, 2030 | $12.54 | $10.22 | $13.99 | +1,443% |
| April, 2030 | $21.62 | $10.13 | $22.57 | +2,562% |
| May, 2030 | $17.77 | $15.93 | $23.67 | +2,088% |
| June, 2030 | $22.65 | $16.84 | $24.04 | +2,689% |
| July, 2030 | $41.91 | $21.76 | $44.25 | +5,060% |
| August, 2030 | $45.42 | $38.52 | $49.89 | +5,492% |
| September, 2030 | $52.40 | $44.07 | $54.17 | +6,351% |
| October, 2030 | $82.96 | $58.45 | $83.56 | +10,115% |
| November, 2030 | $35.08 | $22.86 | $92.22 | +4,219% |
| December, 2030 | $14.36 | $12.15 | $33.14 | +1,669% |
2.82%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):